BiopharmaTrend.com

IT revolution in Life Sciences: startups, innovations, technologies and trends

in fb g+ tw rss

Drug Discovery Insights

Looking at biopharmaceutical startup scene

8 Biopharma Trends and Top Startups to Follow in 2017

   by Andrii Buvailo
8 Biopharma Trends and Top Startups to Follow in 2017

Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, new government policies and regulations, and a changing market conjuncture.

Let’s review some of the most powerful trends that will dominate the industry in 2017 and promising biopharmaceutical startups riding their waves.

Pharma R&D Outsourcing Is On The Rise

   by Andrii Buvailo
Pharma R&D Outsourcing Is On The Rise

Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) as a strategy to stay competitive and flexible in a world of exponentially growing knowledge, increasingly sophisticated technologies and an unstable economic environment.  

According to a recent analytical report by Visiongain, drug discovery outsourcing will continue to grow over the next decade and will rise to a $43.7 billion dollar industry by 2026, as compared to an estimated 19.2 billion in 2016 (or $21.2 billion according to Kalorama Information). This is in line with Vantage’s fresh alliance benchmarking study, revealing that over 80% of bio-pharma respondents report increased alliance activity compared to five years ago. Getting ideas and expertise from external sources is a well-established practice in the pharmaceutical industry with about one-third of all drugs in the pipelines of the top ten pharmaceutical companies initially developed elsewhere, according to a 2014 WSJ article by Jonathan D. Rockoff.  

The Power Of Machine Learning For Drug Discovery

   by Andrii Buvailo
The Power Of Machine Learning For Drug Discovery

An IBM’s executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is yet another sign of a technological transformation unfolding in biopharmaceutical industry.

The newly formed partnership will bring the power of IBM’s supercomputer Watson and its artificial intelligence system to help researchers at Pfizer advance “immuno-oncology”, a potentially promising area for cancer research.